Table 2.
Predictors of vulvar cancer-specific mortality.
Hazard ratio (95% CI) | p-value | |
---|---|---|
Age at diagnosis-category | 0.0046 | |
65–74 years olda | 1.0 | |
75–84 years old | 0.38 (0.18, 0.84) | |
85+ years old | 1.79 (0.78, 4.09) | |
Stage | 0.0009 | |
Ia | 1.0 | |
II | 0.85 (0.31, 2.34) | |
III | 0.62 (0.20, 1.94) | |
IV | 3.17 (1.14, 8.80) | |
Lymph node involvement | < 0.0001 | |
Nonea | 1.0 | |
Lymph node involvement | 7.47 (3.09, 18.04) | |
Surgery performed | < 0.0001 | |
Radical vulvectomy onlya | 1.0 | |
Local excision only | 3.77 (0.75, 18.85) | |
Unilateral or bilateral inguinal LND | 12.77 (2.52, 64.64) | |
Radical vulvectomy + inguinal LND | 2.08 (0.49, 8.83) | |
Adjuvant therapy | <0.0001 | |
Nonea | 1.0 | |
Chemo or radiation therapy only | 59.86 (19.21,186.54) | |
Chemo and radiation therapy | 0.84 (0.36, 2.00) |
Reference group.